Microbot Medical Inc. (MBOT)
NASDAQ: MBOT · Real-Time Price · USD
2.030
-0.090 (-4.25%)
At close: Nov 6, 2025, 4:00 PM EST
2.045
+0.015 (0.74%)
After-hours: Nov 6, 2025, 5:39 PM EST
Microbot Medical Employees
Microbot Medical had 20 employees as of December 31, 2024. The number of employees decreased by 2 or -9.09% compared to the previous year.
Employees
20
Change (1Y)
-2
Growth (1Y)
-9.09%
Revenue / Employee
n/a
Profits / Employee
-$635,400
Market Cap
136.33M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 20 | -2 | -9.09% |
| Dec 31, 2023 | 22 | 4 | 22.22% |
| Dec 31, 2022 | 18 | -2 | -10.00% |
| Dec 31, 2021 | 20 | 6 | 42.86% |
| Dec 31, 2020 | 14 | 3 | 27.27% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
MBOT News
- 1 day ago - Microbot Medical® Commences the Limited Market Release of its LIBERTY® Endovascular Robotic System in the U.S. - GlobeNewsWire
- 21 days ago - Microbot Medical® to Commercially Debut the LIBERTY® System at The Symposium on Clinical Interventional Oncology Annual Meeting - GlobeNewsWire
- 23 days ago - Microbot Medical® Secures U.S. Based Logistics Partner to Support the Commercialization of Its LIBERTY® Endovascular Robotic System - GlobeNewsWire
- 4 weeks ago - Microbot Medical Announces Final Closing of Exercise of Outstanding Preferred Investment Options of Up to $92.2 Million in Gross Proceeds - GlobeNewsWire
- 5 weeks ago - Microbot Medical® Receives First Patent in Japan as it Continues to Broaden its Global Intellectual Property Portfolio - GlobeNewsWire
- 6 weeks ago - Miocrbot Medical® CEO to Discuss Recent FDA Clearance of the LIBERTY® Endovascular Robotic System - GlobeNewsWire
- 7 weeks ago - Microbot Medical Announces First Closing of Exercise of Outstanding Preferred Investment Options of Up to $92.2 Million in Gross Proceeds - GlobeNewsWire
- 7 weeks ago - Microbot Medical Announces Exercise of Outstanding Preferred Investment Options for Up to $92.2 Million in Gross Proceeds - GlobeNewsWire